Diabetic neuropathy

Last reviewed: 28 Aug 2022
Last updated: 07 Jun 2022

Summary

Definition

History and exam

Key diagnostic factors

  • asymptomatic
  • pain (peripheral)
  • loss of sensation (peripheral)
  • dysesthesia (peripheral)
  • reduced or absent ankle reflexes (peripheral)
  • painless injuries (peripheral)
  • resting tachycardia (autonomic)
  • impaired heart rate variability (autonomic)
  • urinary frequency, urgency, nocturia, incontinence, hesitancy, weak stream, or retention (autonomic)
  • erectile dysfunction (autonomic)
  • decreased sexual desire and increased pain during intercourse (autonomic)
  • orthostatic hypotension (autonomic)
More key diagnostic factors

Other diagnostic factors

  • constipation (autonomic)
  • fecal incontinence (autonomic)
  • anhidrosis, heat intolerance, dry skin, or hyperhidrosis (autonomic)
  • hypoglycemia unawareness (autonomic)
  • weakness (peripheral)
  • history of recent falls (peripheral)
  • gait ataxia (peripheral)
  • nausea, postprandial vomiting, bloating, loss of appetite, early satiety (autonomic)
  • heartburn and dysphagia for solids (autonomic)
  • profuse and watery diarrhea (autonomic)
  • specific mononeuropathy (peripheral)
  • cranial neuropathy (peripheral)
  • pain over lower thoracic or abdominal wall (peripheral)
  • thigh muscle atrophy, pain, and weakness (peripheral)
Other diagnostic factors

Risk factors

  • poorly controlled hyperglycemia
  • prolonged duration of diabetes
  • older age (e.g., >70 years)
  • tall stature
  • hypertension
  • dyslipidemia with elevated triglycerides
  • co-existence of multiple cardiovascular disease (CVD) risk factors (type 2 diabetes)
  • obesity
  • immune dysregulation
  • smoking
More risk factors

Diagnostic investigations

1st investigations to order

  • clinical diagnosis
  • fasting blood glucose
  • HbA1c
  • serum thyroid-stimulating hormone
  • serum vitamin B12
  • electrolytes, BUN, creatinine
  • serum lipid profile
  • LFTs
  • CBC and erythrocyte sedimentation rate
  • serum/urine immunoelectrophoresis
  • corneal confocal microscopy
More 1st investigations to order

Investigations to consider

  • 2-hour plasma glucose
  • nerve conduction studies (nerve conduction velocity [NCV])
  • electromyography (EMG)
  • quantitative sensory testing (QST)
  • skin biopsy
  • cardiovascular reflex testing
  • heart rate variability (HRV)
  • gastric emptying studies
  • gastroduodenoscopy
  • barium meal
  • gastrointestinal manometry
  • hydrogen breath tests
  • gastric ultrasonography
  • gastric MRI
  • anorectal manometry
  • fecal fat
  • d-xylose test
  • urine culture
  • cystometry, voiding cystometrogram
  • postvoid urinary tract ultrasound
  • video-urodynamics
  • measurement of nocturnal penile tumescence and of penile and brachial BP
  • serum LH, testosterone, free testosterone, prolactin (morning tests, 8.00-9.00 a.m.)
More investigations to consider

Treatment algorithm

ONGOING

diabetic peripheral neuropathy

cranial neuropathies

limb or truncal mononeuropathies

diabetic amyotrophy

diabetic autonomic neuropathy

Contributors

Authors

Rayaz A. Malik, BSc (Hons), MSc, MBChB, FRCP, PhD

Professor of Medicine

Organizational Official for the Human Research Protection Program

Weill Cornell Medicine - Qatar

Doha

Qatar

Disclosures

RAM has been reimbursed for being on the advisory board for an epidemiologic study on cardiovascular disease in type 2 diabetes and to give educational lectures on treatment of diabetes undertaken by Novo Nordisk. RAM has been reimbursed for educational lectures on diabetes treatment for Sanofi Aventis, Lilly, and Proctor and Gamble (P&G). RAM has reviewed an investigator-initiated grant to study long COVID from P&G. RAM is an author of references cited in this topic.

Uazman Alam, BSc, MBChB, MPHe, PhD

Senior Lecturer and Consultant Physician

University of Liverpool

Liverpool

UK

Disclosures

UA serves on advisory boards for Eli Lilly.

Shazli Azmi, MBchB, MRCP

Consultant Physician

Diabetes and Endocrinology

Central Manchester Foundation Trust

University of Manchester

Manchester

UK

Disclosures

SA declares that she has no competing interests.

Acknowledgements

Dr Rayaz Malik, Dr Uazman Alam, and Dr Shazli Azmi would like to gratefully acknowledge Dr Rodica Pop-Busui and Dr Eva Feldman, the previous contributors to this topic.

Disclosures

RPB declares that she has received speaking honoraria from Pfizer and research support from Amylin Pharmaceuticals; National Institutes of Health/National Heart, Lung, and Blood Institute; National Institute of Health/National Institute of Diabetes and Digestive and Kidney Diseases; American Diabetes Association; and Juvenile Diabetes Research Foundation. RPB and EF are authors of references cited in this topic.

Peer reviewers

Zachary T. Bloomgarden, MD

Clinical Professor

Department of Medicine

Mount Sinai School of Medicine

New York

NY

Disclosures

ZTB declares that he has no competing interests.

Rajesh K. Garg, MD

Assistant Professor of Medicine

Harvard Medical School

Division of Endocrinology

Diabetes and Hypertension

Brigham and Women's Hospital

Boston

MA

Disclosures

RKG has received consultant fees from Aventis and Novartis, and speaker fees from Novartis.

Edward Jude, MBBS, MD, MRCP, DNB

Consultant and Honorary Senior Lecturer

Tameside General Hospital

Diabetes Centre

Ashton Under Lyne

Lancashire

UK

Disclosures

EJ has received funding for conferences and lectures from Pfizer and Boehringer Ingelheim.

  • Diabetic neuropathy images
  • Differentials

    • Uremia
    • Cyanocobalamin deficiency
    • Hypothyroidism
    More Differentials
  • Guidelines

    • Standards of medical care in diabetes - 2022
    • Oral and topical treatment of painful diabetic polyneuropathy: practice guideline update
    More Guidelines
  • Patient leaflets

    Diabetes: what can I do to keep healthy?

    More Patient leaflets
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer